TVRD:NASDAQTvardi Therapeutics, Inc. Analysis
Data as of 2026-09-01 - not real-time
$1.79
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Tvardi Therapeutics, Inc. is bearish at $1.79, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 37.4%. With RSI at 38.9 the momentum picture is approaching oversold, alongside a bullish MACD signal. Recent trading has carved out support near $1.70 and resistance around $2.04.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 374.9% above today's level.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 59.9%, a beta of 0.44 and a maximum drawdown of 96.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 374.9% above today's level.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 59.9%, a beta of 0.44 and a maximum drawdown of 96.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
SUGAR LAND, Texas AP — SUGAR LAND, Texas AP — Tvardi Therapeutics, Inc.Reported topline healthy volunteer results for next-generation STAT3 inhibitor TTI-109, confirming the prodrug design,...Tvardi Therapeutics To Host KOL Webinar On The Clinical Potential Of TTI-109 In Ulcerative Colitis UC And The Evolving...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.35
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.35
- Analyst targets imply +374.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +374.9% versus the current price
- Negative return on equity of -126.2%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-0.8
ROE-126.19%
ROA-55.51%
Debt/Equity1.73
P/B Ratio1.2
Op. Cash Flow$-25029000
Free Cash Flow$-16258125
Industry P/E30.6
Technical Analysis
TrendBearish
RSI38.9
Support$1.70
Resistance$2.04
MA 20$1.83
MA 50$2.30
MA 200$3.35
MACDBullish
VolumeDecreasing
Fear & Greed Index92.95
Valuation
Target Price$8.50
Upside/Downside374.86%
GradeFair
TypeBlend
Risk Assessment
Beta0.44
Volatility59.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.